162 related articles for article (PubMed ID: 38461190)
21. Apolipoprotein B mRNA-Editing Catalytic Polypeptide-Like-Induced Protein Changes in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Throughout Disease Progression.
Bos MK; Smid M; Sleijfer S; Martens JWM
JCO Precis Oncol; 2022 Jan; 6():e2100190. PubMed ID: 35050709
[TBL] [Abstract][Full Text] [Related]
22. Multi-modality analysis supports APOBEC as a major source of mutations in head and neck squamous cell carcinoma.
Faden DL; Thomas S; Cantalupo PG; Agrawal N; Myers J; DeRisi J
Oral Oncol; 2017 Nov; 74():8-14. PubMed ID: 29103756
[TBL] [Abstract][Full Text] [Related]
23. [Mutagenic Activity of AID/APOBEC Deaminases in Antiviral Defense and Carcinogenesis].
Shilova ON; Tsyba DL; Shilov ES
Mol Biol (Mosk); 2022; 56(1):55-68. PubMed ID: 35082258
[TBL] [Abstract][Full Text] [Related]
24. Family-Wide Comparative Analysis of Cytidine and Methylcytidine Deamination by Eleven Human APOBEC Proteins.
Ito F; Fu Y; Kao SA; Yang H; Chen XS
J Mol Biol; 2017 Jun; 429(12):1787-1799. PubMed ID: 28479091
[TBL] [Abstract][Full Text] [Related]
25. The preferred nucleotide contexts of the AID/APOBEC cytidine deaminases have differential effects when mutating retrotransposon and virus sequences compared to host genes.
Chen J; MacCarthy T
PLoS Comput Biol; 2017 Mar; 13(3):e1005471. PubMed ID: 28362825
[TBL] [Abstract][Full Text] [Related]
26. Genetics: A clearer view.
Erdmann J
Nature; 2017 Nov; 551(7679):S44-S45. PubMed ID: 29117162
[No Abstract] [Full Text] [Related]
27. Presence of HIV-1 G-to-A mutations linked to APOBEC editing is more prevalent in non-B HIV-1 subtypes and is associated with lower HIV-1 reservoir.
Abdi B; Lambert-Niclot S; Wirden M; Jary A; Teyssou E; Sayon S; Palich R; Tubiana R; Simon A; Valantin MA; Katlama C; Morand-Joubert L; Calvez V; Marcelin AG; Soulie C
J Antimicrob Chemother; 2021 Jul; 76(8):2148-2152. PubMed ID: 33930161
[TBL] [Abstract][Full Text] [Related]
28. APOBEC-mediated Mutagenesis as a Likely Cause of FGFR3 S249C Mutation Over-representation in Bladder Cancer.
Shi MJ; Meng XY; Lamy P; Banday AR; Yang J; Moreno-Vega A; Chen CL; Dyrskjøt L; Bernard-Pierrot I; Prokunina-Olsson L; Radvanyi F
Eur Urol; 2019 Jul; 76(1):9-13. PubMed ID: 30975452
[TBL] [Abstract][Full Text] [Related]
29. Integrative genomic analysis identifies associations of molecular alterations to APOBEC and BRCA1/2 mutational signatures in breast cancer.
Trevino V
Mol Genet Genomic Med; 2019 Aug; 7(8):e810. PubMed ID: 31294536
[TBL] [Abstract][Full Text] [Related]
30. Potential APOBEC-mediated RNA editing of the genomes of SARS-CoV-2 and other coronaviruses and its impact on their longer term evolution.
Ratcliff J; Simmonds P
Virology; 2021 Apr; 556():62-72. PubMed ID: 33545556
[TBL] [Abstract][Full Text] [Related]
31. Activation-induced deoxycytidine deaminase: Structural basis for favoring WRC hot motif specificities unique among APOBEC family members.
Pham P; Afif SA; Shimoda M; Maeda K; Sakaguchi N; Pedersen LC; Goodman MF
DNA Repair (Amst); 2017 Jun; 54():8-12. PubMed ID: 28388461
[No Abstract] [Full Text] [Related]
32. Identification of new driver and passenger mutations within APOBEC-induced hotspot mutations in bladder cancer.
Shi MJ; Meng XY; Fontugne J; Chen CL; Radvanyi F; Bernard-Pierrot I
Genome Med; 2020 Sep; 12(1):85. PubMed ID: 32988402
[TBL] [Abstract][Full Text] [Related]
33. Analysis of unusual and signature APOBEC-mutations in HIV-1 pol next-generation sequences.
Tzou PL; Kosakovsky Pond SL; Avila-Rios S; Holmes SP; Kantor R; Shafer RW
PLoS One; 2020; 15(2):e0225352. PubMed ID: 32102090
[TBL] [Abstract][Full Text] [Related]
34. Hyperreactive cellular immunity in multiple myeloma.
Reibnegger G; Wachter H; Krainer M; Ludwig H; Herold M; Huber H
Blood; 1992 Apr; 79(8):2174-6. PubMed ID: 1562745
[No Abstract] [Full Text] [Related]
35. [Human Papillomavirus Carcinogenesis Mediated by APOBEC Mutagenesis].
Kukimoto I
Yakugaku Zasshi; 2019; 139(1):75-79. PubMed ID: 30606934
[TBL] [Abstract][Full Text] [Related]
36. RNA binding to APOBEC deaminases; Not simply a substrate for C to U editing.
Smith HC
RNA Biol; 2017 Sep; 14(9):1153-1165. PubMed ID: 27869537
[TBL] [Abstract][Full Text] [Related]
37. Characterizing Mutational Signatures in Human Cancer Cell Lines Reveals Episodic APOBEC Mutagenesis.
Petljak M; Alexandrov LB; Brammeld JS; Price S; Wedge DC; Grossmann S; Dawson KJ; Ju YS; Iorio F; Tubio JMC; Koh CC; Georgakopoulos-Soares I; Rodríguez-Martín B; Otlu B; O'Meara S; Butler AP; Menzies A; Bhosle SG; Raine K; Jones DR; Teague JW; Beal K; Latimer C; O'Neill L; Zamora J; Anderson E; Patel N; Maddison M; Ng BL; Graham J; Garnett MJ; McDermott U; Nik-Zainal S; Campbell PJ; Stratton MR
Cell; 2019 Mar; 176(6):1282-1294.e20. PubMed ID: 30849372
[TBL] [Abstract][Full Text] [Related]
38. CD27 antigen negative expression indicates poor prognosis in newly diagnosed multiple myeloma.
Chu B; Bao L; Wang Y; Lu M; Shi L; Gao S; Fang L; Xiang Q; Liu X
Clin Immunol; 2020 Apr; 213():108363. PubMed ID: 32120013
[TBL] [Abstract][Full Text] [Related]
39. The interesting relationship between APOBEC3 deoxycytidine deaminases and cancer: a long road ahead.
Granadillo Rodríguez M; Flath B; Chelico L
Open Biol; 2020 Dec; 10(12):200188. PubMed ID: 33292100
[TBL] [Abstract][Full Text] [Related]
40. Mutational processes of tobacco smoking and APOBEC activity generate protein-truncating mutations in cancer genomes.
Adler N; Bahcheli AT; Cheng KCL; Al-Zahrani KN; Slobodyanyuk M; Pellegrina D; Schramek D; Reimand J
Sci Adv; 2023 Nov; 9(44):eadh3083. PubMed ID: 37922356
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
